MN
Manishkumar Narshibhai Adroja
About Manishkumar Narshibhai Adroja
Manishkumar Narshibhai Adroja has 12 years in corporate governance. Holds Director role. Currently with 3 companies, including Rajal Laminate Private Limited and Panama Papers Private Limited. Formerly with 1 company, such as Bhimani International Llp. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Rajal Laminate Private Limited
U20296GJ2014PTC079226
|
Director | 04 Mar 2021 | 2014 | Active |
|
Panama Papers Private Limited
U21010GJ2005PTC045371
|
Director | 01 Aug 2014 | 2005 | Active |
|
Safilo Healthcare Private Limited
U21009GJ2023PTC140045
|
Director | 11 Apr 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Bhimani International Llp
ACC-6740
|
Partner | 25 Aug 2023 | 2023 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manishkumar Narshibhai Adroja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manishkumar Narshibhai Adroja
Manishkumar Narshibhai Adroja has 12 years in corporate governance. Holds Director role. Currently with 3 companies, including Rajal Laminate Private Limited and Panama Papers Private Limited. Formerly with 1 company, such as Bhimani International Llp. Engaged in General Business, Healthcare. Contributes to corporate operations.
Manishkumar Narshibhai Adroja is associated with 3 companies as Director.
Manishkumar Narshibhai Adroja has expertise in General Business, Healthcare.
Manishkumar Narshibhai Adroja has 12 years in corporate governance.